AI assistant
Sending…
Arthur J. Gallagher & Co. — Director's Dealing 2017
May 31, 2017
29910_dirs_2017-05-31_50cdda50-bed3-4777-ba49-274e087a49a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALLAGHER ARTHUR J & CO (AJG)
CIK: 0000354190
Period of Report: 2017-05-30
Reporting Person: Cavaness Joel D (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-30 | Common Stock | M | 7400 | $30.95 | Acquired | 113586 | Direct |
| 2017-05-30 | Common Stock | M | 4440 | $23.76 | Acquired | 118026 | Direct |
| 2017-05-30 | Common Stock | M | 11840 | $56.96 | Disposed | 106186 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-30 | Non-qualified Stock Option | $30.95 | M | 7400 | Disposed | 2018-03-08 | Common Stock (7400) | Direct |
| 2017-05-30 | Non-qualified Stock Option | $23.76 | M | 4440 | Disposed | 2018-03-05 | Common Stock (4440) | Direct |
Footnotes
F1: The price reported is an average weighted price. The shares were sold in multiple transactions at prices ranging from $56.94 to $56.98. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The stock option becomes exercisable 20% each year on the anniversary of the grant date.
More from Arthur J. Gallagher & Co.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 24
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 23